Tax

Tax Reconciliation: Other Adjustments

Vertex Pharmaceuticals Tax Reconciliation: Other Adjustments remained flat by 0.0% to $0.07 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 2436.4%, from $0.00 to $0.07. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2024

How to read this metric

Large, frequent adjustments may signal unpredictable tax planning or complex regulatory exposure.

Detailed definition

This represents miscellaneous items in the effective tax rate reconciliation that do not fall into standard categories l...

Peer comparison

Commonly found in the 'other' line item of tax rate reconciliation tables for multinational corporations.

Metric ID: is_cat_tax_reconciliation_other_adjustments

Historical Data

2 years
 FY'23FY'24
Value$0.01$0.28
YoY Change>999%
Range$0.01$0.28
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Vertex Pharmaceuticals's tax reconciliation: other adjustments?
Vertex Pharmaceuticals (VRTX) reported tax reconciliation: other adjustments of $0.07 in Q4 2024.
How has Vertex Pharmaceuticals's tax reconciliation: other adjustments changed year-over-year?
Vertex Pharmaceuticals's tax reconciliation: other adjustments increased by 2436.4% year-over-year, from $0.00 to $0.07.
What does tax reconciliation: other adjustments mean?
Miscellaneous tax adjustments that do not fit into standard reporting categories.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.